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Abstract
Background: Silver nanoparticles (AgNP), the most popular nano-compounds, possess unique properties. Albizia
adianthifolia (AA) is a plant of the Fabaceae family that is rich in saponins. The biological properties of a novel
AgNP, synthesized from an aqueous leaf extract of AA (AAAgNP), were investigated on A549 lung cells. Cell viability
was determined by the MTT assay. Cellular oxidative status (lipid peroxidation and glutathione (GSH) levels), ATP
concentration, caspase-3/-7, -8 and −9 activities were determined. Apoptosis, mitochondrial (mt) membrane
depolarization (flow cytometry) and DNA fragmentation (comet assay) were assessed. The expression of CD95
receptors, p53, bax, PARP-1 and smac/DIABLO was evaluated by flow cytometry and/or western blotting.
Results: Silver nanoparticles of AA caused a dose-dependent decrease in cell viability with a significant increase in
lipid peroxidation (5-fold vs. control; p = 0.0098) and decreased intracellular GSH (p = 0.1184). A significant 2.5-fold
decrease in cellular ATP was observed upon AAAgNP exposure (p = 0.0040) with a highly significant elevation in mt
depolarization (3.3-fold vs. control; p < 0.0001). Apoptosis was also significantly higher (1.5-fold) in AAAgNP treated
cells (p < 0.0001) with a significant decline in expression of CD95 receptors (p = 0.0416). Silver nanoparticles of AA
caused a significant 2.5-fold reduction in caspase-8 activity (p = 0.0024) with contrasting increases in caspase-3/-7
(1.7-fold vs. control; p = 0.0180) and −9 activity (1.4-fold vs. control; p = 0.0117). Western blots showed increased
expression of smac/DIABLO (4.1-fold) in treated cells (p = 0.0033). Furthermore, AAAgNP significantly increased the
expression of p53, bax and PARP-1 (1.2-fold; p = 0.0498, 1.6-fold; p = 0.0083 and 1.1-fold; p = 0.0359 respectively).
Conclusion: Data suggests that AAAgNP induces cell death in the A549 lung cells via the mt mediated intrinsic
apoptotic program. Further investigation is required to potentiate the use of this novel compound in cancer
therapy trials.
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Introduction
Cancer is a leading cause of global morbidity and mor-
tality [1]. In 2006 there were 4525 deaths due to lung
cancer in South Africa [1]. As much as 80-90% of lung
cancer cases are attributed to smoking, with the smaller
proportion (10-20%) as a result of occupational exposure
to heavy metals [2,3]. Much recently, an association has
been found between the acquired immunodeficiency
syndrome (AIDS) and the development of lung cancer [4].
This is of concern considering the crisis of AIDS in South
Africa. The financial strain of anti-retroviral treatment
and cancer therapy necessitates the need for alternate
means of cancer treatment that is cost effective, easily
accessible and safe.
Nanoparticles (NPs) are small sized (1-100 nm) compounds
that are able to function as whole units. These compounds
are becoming widespread for their use in consumer
products and medical applications; with potential for
utilization as therapeutic compounds, transfection vectors,
anti-microbial agents and fluorescent labels [5]. Silver NPs
are the most commercialized and prominent group of
nano-compounds, attributed to their diverse applications
in the health sector.
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Silver (Ag) possesses unique and unusual chemical,
physical as well as biological properties [6]. Silver, in a
colloidal form, is used for the treatment of bacterial
infections in open wounds, and preparation of ointments,
bandages and wound dressings [7]. Additionally, nanosilver
has been used as a contraceptive, and marketed as a
water disinfectant [8,9].
Silver NPs are now being exploited for the treatment
of various diseases such as retinal neurovascularization
[10,11] and acquired immunodeficiency syndrome as a
result of human immunodeficiency virus [12]. Additionally,
AgNPs are well known for their anti-microbial properties
and are used as antiviral agents against hepatitis B, herpes
simplex virus type 1, monkey pox virus and respiratory
syncytial virus [13,14].
Concerns on environmental exposure to AgNPs have
initiated toxicity studies. Silver NP-hydrogel induced
DNA damage and the production of reactive oxygen
species (ROS) in cultured HeLa cells [15]. A study using
human lymphocytes revealed that AgNPs caused DNA
damage and cell death [16]. Additionally, AgNPs induced
oxidative stress and caused impairment of nuclear DNA
in Swiss albino mice [16].
Recently, the use of AgNPs as anti-cancer agents has
proved promising [6]. Various attempts to incorporate
AgNPs into cancer treatments have been made, with
positive outcomes [17]. Although the induction of
oxidative stress by AgNP induced mt damage has
been observed as the general mode of AgNP toxicity,
mechanistic pathways remain unclear [18].
Albizia adianthifolia, a plant member of the Fabaceae
family found abundantly on the east coast of South
Africa, contains saponins such as prosapogenins and
triterpene saponins [19,20]. Saponins are plant glycosides
that were found to induce cell cycle arrest in a
human breast cancer cell line and initiation of apop-
tosis in a leukemia cell line [21]. Additionally, certain
classes of saponins can sequester serum cholesterol
and modulate the immune response [22]. The individ-
ual properties of Ag and AA were considered for the
synthesis of a novel AgNP using aqueous leaf extracts
of the plant.
The A549 cell line (human lung carcinoma) is well
characterized and extensively used in in vitro nanotoxocity
studies [23]. A recent study postulated that the in-
duction of ROS and alterations in mt membrane
permeability were possible mechanisms by which
AgNP exerted its toxic effects in A549 cells [24].
The aim of this study was to investigate the effects
of AAAgNP on lung cancer cells. It was hypothesized
that AAAgNP induced cell death by apoptosis as a
result of AAAgNP mediated generation of ROS. We
report on a possible mechanism by which AAAgNP
induced apoptosis in the A549 cells.
Results
Cell viability assay
Toxicity of AAAgNP to A549 cells was determined using
the MTT assay. A dose-dependent decline in cell viability
was observed using AAAgNP concentrations in the range 0
to 75 μg/ml for 6h (95% Cl = 31.96 to 57.72) (Figure 1).
An IC50 value of 43 μg/ml was obtained and used in all
subsequent assays.
ATP analysis
Levels of ATP were assessed using luminometric assay.
Silver nanoparticles of AA significantly reduced ATP
levels with a 2.5-fold decrease (350,000 ± 1500RLU; 95%
CL = 330,000 to 370,000) compared to the control
(990,000 ± 40,000RLU; 95% Cl = 480,000 to 1,500,000;
p = 0.0040) (Figure 2).
Oxidative status
Glutathione concentrations were measured as a marker
for intracellular anti-oxidant capacity. The concentration
of GSH was higher in untreated cells (15 ± 1.3 μM)
compared to AAAgNP treated cells (12 ± 0.24 μM, 95%
Cl = −1.0 to 6.2; p = 0.1184) (Figure 3A). Lipid peroxidation
(MDA) was significantly 5-fold higher in cells exposed
to AAAgNP (0.16 ± 0.023 μM) compared to controls
(0.032 ± 0.016 μM, 95% Cl = −0.21 to −0.049; p = 0.0098)
(Figure 3B).
Analysis of caspases
AAAgNP significantly increased the activities of caspase-3/-7
(1.7-fold, 95% Cl = −1,000,000 to −260,000; p = 0.0180)















Figure 1 A dose-dependent decline in A549 cell viability after
AAAgNP treatment. The MTT assay was used to determine effect of
AAAgNP on A549 cell viability. Cells were exposed to AAAgNP in the
range 0-75 μg/ml for 6h, after which the formazan product was
quantified spectrophotometrically. A distinct dose dependent effect
was observed where AAAgNP at lower concentrations induced
minimal cell death. A gradual decrease in cell viability occurred with
increasing AAAgNP concentration (95% Cl = 31.96 to 57.72). An IC50
value of 43 μg/ml was obtained and used for subsequent assays.
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and −9 (1.4-fold, 95% Cl = −610,000 to −220,000; p =
0.0117) compared to the control. The activity of caspase-8
however was significantly decreased by AAAgNP compared
to untreated cells (2.5-fold, 95% Cl = 550,000 to 840,000;
p = 0.0024) (Table 1).
Flow cytometry
Silver nanoparticles of AA significantly increased PS trans-
location A549 cell compared to the control (57 ± 0.59% vs.
10 ± 0.84%, 95% Cl = −50 to −43; p < 0.0001) (Figure 4A).
Additionally, the percentage of necrotic cells were also
significantly higher in AAAgNP treated cells (17 ± 0.79% vs.
control: 4.6 ± 0.70%, 95% Cl = −16 to −9.2; p < 0.0001)
(Figure 4A). The apoptosis inducing potential of AAAgNP
was further verified in disrupting mt ΔΨ. The treated cells
had significantly higher mt depolarization compared to
untreated cells (77 ± 0.88% vs. 23 ± 1.8%, 95% Cl = 44 to 57;
p < 0.0001) (Figure 4B).
The expression of CD95 was significantly down regulated
(2-fold; 2.8 ± 0.58% vs. control: 5 ± 0.44%, 95% Cl = 0.13 to
4.2; p = 0.0416) (Table 2). In contrast, AAAgNP significantly
increased the expression of smac/DIABLO, a pro-apoptotic
protein (29 ± 0.32%) compared to the control (18 ± 0.66%,
95% Cl = −13 to −8.5; p < 0.0001) (Table 2). Additional files
contain the histograms for extra- and intracellular
staining (see Additional file 1: Figure S1 and Additional
file 2: Figure S2 respectively).
Comet assay
Silver nanoparticles of AA were significantly genotoxic to
A549 cells as noted by the increased DNA fragmentation.
Comet tail lengths were significantly longer in treated
(90 ± 1.3 μm) compared to untreated cells (20 ± 0.71 μm,
95% Cl = −73 to −67; p < 0.0001) (Figure 5).
Western blot analysis
The expression of selected apoptotic proteins and
validation of flow cytometric intracellular stained
smac/DIABLO was determined by western blotting.
The expression of p53 was observed to be significantly
higher post AAAgNP exposure (1.0 ± 0.018RBI vs. control:
0.82 ± 0.045RBI, 95% Cl = −0.42 to −0.00037; p = 0.0498). A
significant increase in the 24kDa fragment of PARP-1 was
noted after AAAgNP treatment (3.5 ± 0.069RBI vs. control:
3.1 ± 0.0043RBI, 95% Cl = −0.65 to −0.058; p = 0.0359).
Evaluation of bax showed higher levels of the protein in
cells that were treated with AAAgNP (3.4 ± 0.11RBI)
compared to untreated cells (2.1 ± 0.047RBI, 95% Cl = −1.9
to −0.81; p = 0.0083). Highly significant differences were
seen in the expression of smac/DIABLO between experi-
mental and control cells. Silver nanoparticles of AA treated
cells presented with a 4.1-fold greater band intensity
(1.1 ± 0.045RBI vs. control: 0.27 ± 0.010RBI, 95% Cl = −0.99
to −0.59; p = 0.0033) (Figure 6).
Discussion
Several pathological syndromes such as liver failure,
stroke or heart attack are associated with abrupt death
of tissue or organs as a result of apoptotic dysregulation.














Figure 2 Levels of ATP in control and AAAgNP treated A549 cells.
Cellular ATP levels were detected by the ATP CellTitre Glo assay
(Promega, Madison, USA). A significant decline in ATP was noted after
treatment with AAAgNP (350000 ± 1500RLU; 95% CL = 330000 to 370000)
compared to the control cells (990000 ± 40000RLU; 95% Cl = 480000 to
1500000; p = 0.0040). RLU: relative light units.
Figure 3 A) Levels of GSH and B) MDA (lipid peroxidation) in AAAgNP treated and untreated cells. The oxidative status of A549 cells were
assessed by quantifying GSH and MDA. Levels of the anti-oxidant GSH were measured by the GSH-Glo™ Glutatione assay (Promega, Madison, USA).
AAAgNP caused a decrease in GSH (12 ± 0.24 μM) compared to untreated cells (15 ± 1.3 μM, 95% Cl = −1.0 to 6.2; p = 0.1184). The TBARS assay was
utilized to quantify MDA levels as marker for lipid peroxidation induced by ROS. A significant elevation in MDA levels were found in cells exposed to
AAAgNP (0.16 ± 0.023 μM) compared to the control (0.032 ± 0.016 μM, 95% Cl = −0.21 to −0.049; p = 0.0098).
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apoptosis, may lead to tumorigenesis [25]. Apoptosis is
commonly altered in cancerous cells, which have the
ability to evade the apoptotic cascade.
Silver nanoparticles of AA significantly increased PS
externalization, a transmembrane glycoprotein, in the
treated A549 cells (Figure 4A).
The signal transduction of apoptosis involves a cascade
of initiator and executioner caspases [26]. Executioner
caspases-3/-7 cleave specific substrates leading to
alteration changes linked with apoptosis and ultimately
cell death [27]. Initiator caspses-8 and −9 are responsible
for the activation of executioner caspases. Silver
nanoparticles of AA significantly up regulated the activities
of caspases-3/-7 and −9 (Table 1). Furthermore AAAgNP
increased DNA fragmentation (Figure 5)-an end stage
characteristic of apoptosis. In response to this DNA
damage, the nuclear enzyme PARP-1 catalyzes the transfer
of NAD+ to a specific set of nuclear substrates [28]. During
apoptosis, PARP-1 is cleaved, by executioner caspases-3/-7,
to a 24kDa DNA binding domain and an 89kDa fragment
containing catalytic activity. Silver nanoparticles of AA was
responsible for the cleavage of PARP-1 as evidenced by the
significantly increased expression of 24kDa fragment
compared to untreated control cells (Figure 6B).
Mitochondria play an important role in apoptosis, via
the intrinsic apoptotic program. An initial step for
activation of the intrinsic apoptotic pathway is the
depolarization of the mt membrane. Depolarized mt is
as a result of the formation of mt permeability transition
(PT) pores [29]. Mitochondrial PT has been associated
with various metabolic consequences such as halted
functioning of the electron transport chain with
associated elevation in ROS and decreased production of
ATP [30]. Bax, a pro-apoptotic protein of the Bcl-2
family, translocates from the cytosol to the outer mt
membrane during apoptosis where it interacts with
lipids and induces mt PT pores. A significant increase in
mt depolarization was observed after AAAgNP treatment
(Figure 4B), with an accompanying decrease in ATP
concentration (Figure 2). The high levels of bax expression
(Figure 6C), high mt depolarization and decreased ATP
suggest that AAAgNP induces cellular apoptosis in cancer-
ous lung cells via the intrinsic apoptotic pathway.
Silver has a high affinity for thiol (−SH) groups [31].
In this study, the levels of cysteine-rich GSH were
decreased whilst lipid peroxidation was significantly
elevated by AAAgNP (Figure 3). This oxidant/anti-oxidant
imbalance has previously been documented as an apop-
totic mechanism by AgNP mediated cytotoxicity [32,33].
The extrinsic apoptotic pathway is mediated by CD95
death receptor, which recruits Fas-associated protein
with death domain (FADD) adapter protein. The adapter
protein FADD binds to and activates caspase-8 via the
formation of a death-inducing signaling complex [25].
The results of this study show that CD95 expression
(Table 2) and caspase-8 activity (Table 1) was signifi-
cantly decreased by AAAgNP. The extracts of AA are rich
in saponins, which will promote rapid entry of the
AAAgNP into the cells resulting in mt mediated intrinsic
apoptotic pathway. A well characterized biological action
of saponins is their ability to induce cell membrane
permeabilization [34]. Decreased ATP concentrations
and increased MDA as a result of ROS may be due to
disruptions in the mt respiratory chain. Nanoparticles
preferentially localize in mt and cause oxidative stress as
Figure 4 A) Percentages of apoptotic and necrotic cells and B) Mt depolarization after treatment with AAAgNP. Flow cytometry was used
to examine PS translocation (annexin-V-Fluos assay (Roche)) and mt membrane integrity (BD™ MitoScreen kit (BD Biosciences). A significant increase in
apoptosis (57 ± 0.59% vs. control: 10 ± 0.84%, 95% Cl = −50 to −43; p < 0.0001) and necrosis (17 ± 0.79% vs. control: 4.6 ± 0.70%, 95% Cl = −16 to −9.2;
p < 0.0001) following treatment was seen. Furthermore, mt membrane depolarization was significantly higher in AAAgNP treated cells (77 ± 0.88% vs.
control: 23 ± 1.8%, 95% Cl = 44 to 57; p < 0.0001).
Table 1 Caspase activity in AAAgNP treated cells
Control AAAgNP
Mean RLU ± sem Mean RLU ± sem p value
CASPASE-8 1.2 × 106 ± 2.6 × 104 4.6 × 105 ± 2.3 × 104 0.0024**
CASPASE-9 9.2x105 ± 3.3 × 104 1.3x106 ± 3.1 × 104 0.0117*
CASPASE-3/-7 9.2x105 ± 4 × 103 1.6x106 ± 8.6 × 104 0.0180*
RLU: relative light units.
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well as potentiate structural damage [35,36]. Various studies
have associated AgNP toxicity with mt damage [37,38].
Several pro-apoptotic molecules are released from the
mt during apoptosis. In the presence of ATP, mt released
cytochrome c associates with apoptotic protease-activating
factor (Apaf)-1 in the cytosol inducing its oligomerization.
An apoptosome is then formed with the oligomeric Apaf-1
complex and procaspase-9, inducing the activation of
caspase-9, which in turn activates effector caspases-3
and −7 [26]. An interesting finding in this study was that
although ATP levels were reduced post AAAgNP treatment,
the activity of caspase-9 was still elevated (Table 1).
A class of molecules involved in the regulation of
apoptosis is the inhibitor of apoptosis (IAP) proteins.
These proteins avert cell death by suppressing the activity
of caspases. X-chromosome-linked inhibitor of apoptosis
(XIAP) is the most well characterized member of IAPs
[25]. The ability of IAPs to act as endogenous suppressors
of procaspase activation is attributed to the presence of
domains referred to as baculoviral IAP repeats (BIR).
In particular, BIR3 and a region adjacent to BIR2 are
responsible for the inhibition of caspases-9, and −3
and −7 respectively. Smac/DIABLO, a mt protein, is able
to abolish the inhibitory effects of XIAP [26]. Both smac/
DIABLO and caspases-3,-7 and −9 contain IAP-binding
motifs that fit into the BIR domains of XIAP. Thus, smac/
DIABLO is able to relieve inhibition by replacing and
releasing caspases-3, -7 and −9 from the XIAP inhibitory
complex [25,26]. We postulated that AAAgNP released
smac/DIABLO from the mt. The increased intracellular
staining (Table 2) and expression of smac/DIABLO by
western blotting (Figure 6D) confirmed that AAAgNP
induced its release from the mt.
The p53 protein mediates a range of anti-proliferative
processes in response to different stress stimuli by directly
activating apoptosis and promoting the release of bax [39]
and inducing executioner caspase activity [40] Also, p53
interferes with mt integrity and function leading to the
release of pro-apoptotic molecules and the generation of
ROS [41]. This study clearly shows the increased expression
of p53 after addition of AAAgNP to cells (Figure 6A).
Conclusion
In conclusion, this novel AAAgNP possesses potent pro-
apoptotic potential. We have shown, mechanistically, that
AAAgNP activates the intrinsic apoptotic pathway in A549
lung carcinoma cells. The findings of this study suggest the
potential for AAAgNP in drug development against cancer.
None the less, further studies need to be conducted to
ascertain if the effects of AAAgNP are consistent in other
cancerous cell lines and also non-toxic to healthy systems.
Materials and methods
Materials
A549 cells were purchased from Highveld Biologicals
(Johannesburg, South Africa). Cell culture reagents were
purchased from Whitehead Scientific (Johannesburg,
South Africa). LumiGLOW chemiluminescent substrate
kit was purchased from Gaithersburg (USA) and western
blot reagents were purchased from Bio-Rad (USA). All
other reagents were purchased from Merck (South Africa).
Synthesis of AAAgNP
Synthesis and characterization of AAAgNP, described by
Gengan et al. 2013, was conducted at the Steve Biko
campus, Durban University of Technology, Durban, South
Africa. A one-pot green synthesis technique was used [42].
Briefly, fresh leaves of AA were extracted with deionized
water. The crude extract was filtered and the supernatant
was allowed to react with silver nitrate solution at room
temperature (RT). Silver nanoparticles of AA solution
(pH 7) were then characterized using UV spectrometry.
Particle size was determined by transmission electron
microscopy. To assess the interaction between nanosilver
Table 2 Surface expression of CD95 and intracellular
smac/DIABLO in A549 cells treated with AAAgNP as
determined flow cytometrically
Control AAAgNP
Mean % ± sem Mean % ± sem p value
FITC + ve (CD95) 5 ± 0.44 2.8 ± 0.58 0.0416*
APC + ve
(smac/DIABLO)
18 ± 0.66 29 ± 0.32 <0.0001***
Figure 5 Fragmentation of DNA in cells exposed to AAAgNP (B)
and untreated control cells (A) (100x). To assess the genotoxic
effects of AAAgNP, the comet assay was used. Fragmentation of DNA
(indicated by comet tails) was significantly induced by AAAgNP
treatment (90 ± 1.3 μm) compared to control cells (20 ± 0.71 μm,
95% Cl = −73 to −67; p < 0.0001).
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and compounds of the aqueous extracts of AA leaves, Fou-
rier transform infrared spectrophotometry was employed
[42]. Ethical approval from the Biomedical Research
Ethics Administration Office of the University of KwaZulu-
Natal (Reference number: BE050/08) was obtained.
Cell culture and exposure protocol
The A549 cells were cultured in Eagle’s minimum essen-
tial medium supplemented with 1% L-glutamine, 1%
penstrepfungizone and 10% fetal bovine serum. Cultures
were maintained at 37°C with 5% CO2. For the 3-(4,5-
Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) assay, cells were seeded into a 96-well microtitre
plate, allowed to attach overnight and treated with AAAgNP
solution (0-75 μg/ml). For flow cytometry assays, caspase,
ATP and lipid peroxidation assays, cells were cultured to
90% confluency in 25 cm2 tissue flasks and treated with
AAAgNP. For the GSH assay, cells were plated in 96-well
microtitre plates and allowed to attach overnight, followed
by treatment with AAAgNP. For western blot analysis and
the comet assay, cells were grown to 90% confluency in
6-well culture plates and treated with AAAgNP.
Cell viability assay
Cell viability was determined using the MTT assay.
Approximately 20,000 cells (in six replicates) were used
for exposure to AAAgNP concentrations in the treatment
range. After incubation with AAAgNP for 6 h, cells were
washed twice with 0.1M phosphate buffer saline (PBS) and
incubated with MTT salt solution (5mg/ml in 0.1M PBS)
and complete culture medium (37°C, 4 h). Thereafter, 100 μl
of dimethyl sulfoxide was added to each well and incubated
(37°C, 1 h). Optical density of the formazan product was
measured using a spectrophotometer (Bio-tek μQuant) at
570/690 nm. The results were expressed as percentage cell
viability vs. concentration of AAAgNP, from which the half
maximal inhibitory concentration (IC50) was determined.
ATP assay
Cells (20,000/well in six replicates) were aliquoted in an
opaque 96-well microtitre plate to which the ATP
CellTitre Glo (Promega, Madison, USA) reagent (50 μl)
was added and allowed to react in the dark (30 min, RT).
After incubation, the luminescent signal proportional to the
cellular ATP content was detected with a Modulus™
microplate reader (Turner Biosystems, Sunnyvale, USA).
The results were expressed as mean relative light
units (RLU).
Glutathione assay
The GSH-Glo™ Glutatione assay (Promega, Madison, USA)
was utilized to quantify intracellular GSH levels. Subsequent
Figure 6 The expression of apoptotic proteins (A) p53, B) PARP-1, C) bax and D) smac/DIABLO) in AAAgNP treated and untreated cells.
Western blotting assessed the expression of selected apoptotic proteins. Levels of p53 were significantly higher post AAAgNP exposure
(1.0 ± 0.018RBI vs. control: 0.82 ± 0.045RBI, 95% Cl = −0.42 to −0.00037; p = 0.0498). Cleavage of PARP-1 was distinct with significant increase in the
24kDa fragment after AAAgNP treatment (3.5 ± 0.069RBI vs. control: 3.1 ± 0.0043RBI, 95% Cl = −0.65 to −0.058; p = 0.0359). The expression of bax
was significantly higher in cells that were treated with AAAgNP (3.4 ± 0.11RBI) compared to untreated cells (2.1 ± 0.047RBI, 95% Cl = −1.9 to −0.81;
p = 0.0083). AAAgNP treated cells presented with a 4.1-fold greater band intensity for smac/DIABLO (1.1 ± 0.045RBI vs. control: 0.27 ± 0.010RBI,
95% Cl = −0.99 to −0.59; p = 0.0033). Protein bands were standardized against β-actin.
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to treatment of cells (10,000 cells/well in six replicates) in
an opaque 96-well microtitre plate, culture medium was
removed and 25 μl of 1X GSH-Glo™ reagent (prepared
according to manufacturer’s guidelines) was added to each
well. Glutathione standards (0-5M) were serially diluted
(two-fold) from a 5mM stock in deionized water. After
brief mixing on a shaker and 30 min incubation at RT,
100 μl of Luciferin detection reagent was added to the
wells (15 min, RT). Luminescence was detected on a
Modulus™ microplate luminometer (Turner Biosystems,
Sunnyvale, USA). A calibration curve was constructed and
sample GSH concentrations (μM) were calculated.
Lipid peroxidation
To investigate the AAAgNP-mediated generation of reactive
oxygen species (ROS), malondialdehyde (MDA-a product
of lipid peroxidation) levels were measured using the
thiobarbituric acid reactive substances (TBARS) assay.
Briefly, the following was added to a set of test tubes:
200 μl of 2% H3PO4, 400 μl of 7% H3PO4, 400 μl of TBA/
BHT solution and 200 μl of 1M HCL. Following treatment
of cells (50,000 cells/well) in a 6-well plate, supernatants
were recovered. For test samples, 100 μl of cell supernatant
(in triplicate) was then added to each test tube. A positive
control was prepared by adding 1 μl of MDA to a test tube.
All tubes were incubated in a water bath (100°C, 15 min)
and after cooling; butanol (1.5ml) was added to each tube,
vortexed for 10 seconds and allowed to separate into two
distinct phases. Approximately 800 μl of the upper butanol
phase was then transferred to 1.5ml tubes and centrifuged
(840 x g, 24°C; 6 min). To a 96-well micotitre plate, 100 μl
of supernatant was transferred in six replicates and the
absorbance read using a spectrophotometer (Bio-tek
μQuant) at 532/600 nm. The mean absorbance was divided
by the extinction co-efficient (156mM-1) and results were
expressed as μM concentrations.
Assessment of caspase activity
Caspase-3/-7, -8 and -9 activities were detected with
Caspase-GloW assays (Promega, Madison, USA). As
per manufacturer’s protocol, Caspase-GloW-3/-7, -8
and -9 reagents were reconstituted and added to wells
(in six replicates) of an opaque 96-well microtitre plate
(40 μl of reagent per 100 μl of 10,000 cells/well). Samples
were mixed and incubated in the dark (30 min, RT).
The luminescent signal was measured on a Modulus™
microplate luminometer (Turner Biosystems, Sunnyvale,
USA). Caspase-3/-7, -8 and -9 activities were expressed as
relative light units (RLU).
Annexin-V-FLUOS assay
The annexin-V-Fluos assay (Roche) was used to deter-
mine phosphatidylserine (PS) translocation. To each flow
cytometry tube, 100 μl of staining buffer, 100 μl of
annexin-V-Fluos labeling solution (annexin-V: propidium
iodide (PI): staining buffer (1:1:50 vol/vol/vol)) and 100 μl
of cell suspension was added, and incubated in the dark
(15 min, RT). Samples were analyzed on a FACS Calibur
(BD Biosciences) flow cytometer. Data were analyzed
using CellQuest PRO v4.02 software (BD Biosciences).
Cells were gated to exclude cellular debris using FlowJo
v7.1 software (Tree Star, Inc). Approximately 50,000
events were analyzed for apoptotic (annexin-V + ve, PI -ve),
necrotic (annexin-V + ve, PI + ve) and live cells (annexin-
V -ve, PI -ve). The results were expressed as percentage
of the total events.
JC-1 MitoScreen assay
Mitochondrial membrane potential (Δ Ψ) was assayed
with the BD™ MitoScreen kit (BD Biosciences). JC-1, a
cationic dye, is sensitive to Δ Ψ and accumulates in mt
with polarized membranes. JC-1 working solution was
prepared and 100 μl added to each flow cytometry tube,
followed by 100 μl of cell suspension. Tubes were
incubated at 37°C with 5% CO2 for 15 min, after which
100 μl of JC-1 wash buffer was added. Approximately
50,000 events were analyzed for mt depolarization. A
FACS Calibur flow cytometer was used and data were
analyzed using CellQuest PRO v4.02 software. Cells
were gated to exclude cellular debris using FlowJo v7.1
software. The results were expressed as percentage of
the total events.
Comet assay
The comet assay was used to determine DNA fragmen-
tation in the AAAgNP treated lung cells. Briefly, three
slides per sample were prepared with a first layer
containing 400 μl of 1% low melting point agarose
(LMPA, 37°C), a second layer of 25 μl of cells from each
sample with 175 μl 0.5% LMPA (37°C) and a third layer
containing 200 μl of 1% LMPA (37°C). Cover slips were
removed and slides were subjected to lysis (4°C, 1 hr,
protected from light) by being submerged in cells lysis
buffer (2.5M NaCl, 100mM EDTA, 1% Triton X-100,
10 mM Tris (pH 10) and 10% DMSO). The slides were
equilibrated in electrophoresis buffer (300 mM NaOH,
1 mM Na2EDTA, pH 13; 20 min) then electrophoresced
(300 mA, 25V, 35 min) after which slides were washed
three times (0.4M Tris, pH 7.4; 5 min) and finally stained
with 40 μl ethidium bromide. Cover slips were placed
onto slides and maintained overnight at 4°C. Slides were
viewed using a fluorescent microscope (Olympus IXSI
inverted microscope/510-560 nm excitation and 590 nm
emission wavelengths). Images were captured and comet
tails of 50 cells were measured using Life Science-Soft
Imaging System (analySISW v5). The results were expressed
as mean tail length in μm.
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CD95 (Fas) analysis
CD95 receptor expression was determined by cell
surface staining on a flow cytometer. Briefly, 100 μl
of 0.1M PBS and 1 μl of fluorescein isothiocyanate
(FITC) conjugated mouse anti-human CD95 antibody
(BD Pharmingen, 555673) was added to 100 μl of cell
suspension. Reaction mixture was incubated in the
dark for 15 min at RT, thereafter run on a FACS
Calibur. Data were analyzed using CellQuest PRO
v4.02 software. Cells were gated to exclude cellular
debris using FlowJo v7.1 software. The results were
expressed as a percentage.
Intracellular staining
Intracellular levels of smac/DIABLO were assessed by flow
cytometry. Cells were rendered permeable by incubation in
Fix and Perm medium A (Caltag) (15 min in the dark),
after which they were treated with Fix and Perm medium
B (Caltag) containing monoclonal anti-smac/DIABLO pri-
mary antibody (smac/DIABLO, ab110291) (1:500; 30 min,
RT). After washing, cells were re-suspended in medium B
containing allophycocyanin (APC) conjugated anti-mouse
secondary antibody (Thermo Scientific, 31430) (1:100;
15 min, RT) protected from light. Cells were then washed,
re-suspended in 0.1M PBS and run on a FACS Calibur.
Data were analyzed using CellQuest PRO v4.02 software.
Cells were gated to exclude cellular debris using FlowJo
v7.1 software. The results were expressed as percentage.
Western blot analysis
Cytobuster™ reagent (Novagen) supplemented with
protease and phosphatase inhibitors (Roche, 05892791001
and 04906837001 respectively) was used for protein
isolation. Cytobuster (200 μl) was added to the cells (4°C,
10 min) and centrifuged (180 x g; 4°C, 10 min) to obtain a
crude protein extract. Protein samples were quantified
using the bicinchoninic assay and standardized to 1mg/ml.
Samples (25 μl) were electrophoresced on 7.5% sodium
dodecyl sulfide-polyacrylamide gel electrophoresis gels
and thereafter transferred to nitrocellulose membranes.
Membranes were blocked with 3% bovine serum albumin
(BSA) in Tris buffer saline (20mM Tris–HCl (pH 7.4),
500mM NaCl and 0,01% Tween 20 (TBST)) for 1 h, and
incubated with primary antibody (p53, ab26; bax, ab5714;
parp-1, ab110915; smac/DIABLO, ab110291 and β-actin,
ab8226; 1:1,000) in 1% BSA in TBST at 4°C overnight.
Membranes were then washed thrice (10ml TBST, 15 min)
and treated with horseradish peroxidase-conjugated
secondary antibody (mouse, ab97046; 1:2,000) (1 h, RT).
Membranes were washed again 3 times (TBST, 15 min)
and immunoreactivity was detected by the LumiGLOW
chemiluminescent substrate system (KPL) with the Uvitech
Image Documentation System (UViTech Alliance 2.7).
Protein bands were analyzed with the UViBand Advanced
Image Analysis software (UViTech v12.14). The results
were expressed as mean relative band intensity (RBI).
Statistical evaluation
Statistical analyses were performed using GraphPad Prism
version 5.00 software package (GraphPad PRISMW). Data
are expressed as mean ± standard error of the mean (sem).
Comparisons were made using unpaired t tests. Statistical
significance was set at 0.05.
Additional files
Additional file 1: Figure S1. Extracellular staining-flow cytometry was
used to evaluate the expression of CD95 (Fas receptor). Three replicates
were done for both treated (B1-B3) and untreated (A1-A3) cells.
AAAgNP significantly down regulated the expression of CD95 in A549
cells compared to the control (2.8 ± 0.58% vs. 5 ± 0.44%; p = 0.0416;
95% Cl = 0.13 to 4.2).
Additional file 2: Figure S2. Levels of smac/DIABLO, a pro-apoptotic
protein, were determined flow cytometrically using an intracellular staining
assay. A significantly higher expression of smac/DIABLO was observed in
A549 cells after treatment with AAAgNP (B1-B3) compared to untreated
cells (A1-A3) (29 ± 0.32% vs. 18 ± 0.66%; p < 0.0001; 95% Cl = -13 to -8.5).
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